Please login to the form below

Not currently logged in
Email:
Password:

Stada

This page shows the latest Stada news and features for those working in and with pharma, biotech and healthcare.

Takeda to sell Japan consumer health unit for $2.3bn

Takeda to sell Japan consumer health unit for $2.3bn

The Japanese pharma also entered an agreement with Stada last October to divest a portfolio of select OTC drugs for a total value of $660m. ... The Stada deal includes OTC vitamins and food supplements, and select products in the cardiovascular, diabetes,

Latest news

  • GlaxoSmithKline reportedly looking to sell select antibiotic brands GlaxoSmithKline reportedly looking to sell select antibiotic brands

    GSK also sold of its 15 consumer brands to German pharma company Stada Arzneimittel AG for over 300m around the same time. ... The Stada deal was just the latest in a string of divestments – in January GSK signed a deal worth up to 955m with Bavarian

  • Takeda divests over-the-counter and prescription drugs to Stada for $660m Takeda divests over-the-counter and prescription drugs to Stada for $660m

    Japanese drug-maker Takeda has entered an agreement with German pharma Stada to divest a portfolio of select over-the-counter (OTC) and prescription drugs for a total value of $660m. . ... The portfolio of products to be divested to Stada and Acino

  • Post-merger Celgene to lead pharma growth Post-merger Celgene to lead pharma growth

    Behind Celgene is a cohort of five companies which are expected to post profit growth of 6-10%: AbbVie, AstraZeneca, Eli Lilly, Stada and Takeda.

  • Stada's €4.1bn takeover goes through Stada's €4.1bn takeover goes through

    German pharma company finally comes under new ownership. After months of wrangling, German pharma company Stada has finally come under new ownership after a successful tender by private equity firms Bain ... The buyout - which is the largest for a

  • Time running out on new Stada takeover bid Time running out on new Stada takeover bid

    Only 34% of shareholders have backed the deal so far. With a deadline looming on Wednesday, only a third of shareholders in German pharma company Stada have accepted the takeover bid ... As of Friday around 34% of Stada's shareholders had accepted, well

More from news
Approximately 10 fully matching, plus 12 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    Given this background what do we make of the deal where two private equity companies, Bain and Cinven, joined forces to acquire Stada for $5.63bn? ... So why did Bain/Cinven acquire Stada at a high price? Almost certainly it was because they were in

  • Deal Watch February 2017 Deal Watch February 2017

    What is more than rumour, is the interest from several parties in acquiring the German generic company, Stada, which has pan-European capabilities and a foothold in Russia. ... Whatever happens to Stada this represents another chapter in the evolution of

  • Deal Watch table for August 2013 Deal Watch table for August 2013

    485. OptiMedica  /. Abbott. Acquisition. Ophthalmic device company. 400. Thornton &Ross /. Stada Arzneimittel. Acquisition. OTC manufacturer. 345. Endosense  /. St Jude Medical.

  • Pharma deals during August 2013 Pharma deals during August 2013

    Generics business consolidation was also evident on this side of the pond. In a defensive move the German drugmaker Stada Arzneimittel announced the $345m take-over of the UK OTC company, ... Thornton &Ross.Thornton &Ross is one of the fastest growing

  • Pharma deals during November 2012 Pharma deals during November 2012

    the subject of interest from companies such as GSK and Stada for some time. It is currently majority owned by Russia's largest drugstore chain “36.6” and has enjoyed 20

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Britannia promotes Robert Wood Britannia promotes Robert Wood

    Prior to joining Britannia, which is part of Stada, in early 2011, his roles included business unit director, pharmaceuticals at International SOS and vice president of business development at Optasia Medical.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....